Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates
The unprecedented and rapid spread of SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) has motivated the need for a rapidly producible and scalable vaccine. Here, we developed a synthetic soluble SARS-CoV-2 spike (S) DNA-based vaccine candidate, GX-19. In mice, immunization with GX-19 el...
Main Authors: | Yong Bok Seo, You Suk Suh, Ji In Ryu, Hwanhee Jang, Hanseul Oh, Bon-Sang Koo, Sang-Hwan Seo, Jung Joo Hong, Manki Song, Sung-Joo Kim, Young Chul Sung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/4/307 |
Similar Items
-
Influenza Virus Infection in Nonhuman Primates
by: Erik A. Karlsson, et al.
Published: (2012-10-01) -
Accelerating the evolution of nonhuman primate neuroimaging
by: Milham, M, et al.
Published: (2020) -
The nonhuman primate neuroimaging and neuroanatomy project
by: Hayashi, T, et al.
Published: (2021) -
Transgenic nonhuman primates for neurodegenerative diseases
by: Chan Anthony WS
Published: (2004-06-01) -
Vaccine delivery with microneedle skin patches in nonhuman primates
by: Li, Adrienne Victoria, et al.
Published: (2014)